For example, CD26 overexpression was associated with tumor aggressiveness in many cancer types such as astrocytomas [21], lymphomas [22], urothelial carcinoma [23], colorectal cancer [24], and gastrointestinal stromal tumors [25]. This evidence concerns the gene DPP4 and urothelial carcinoma.